Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | GFER | P55789 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 9/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28081739 | 0.94 | CYP3A4 (0.44) | ALDH1A1CYP3A4GFERTSHRTDP1 | |
| SCHEMBL11392894 | 0.88 | CA2 (0.39) | CYP3A4TSHRMAOBMAOACA2 | |
| SCHEMBL10103182 | 0.83 | MAOB (0.44) | ALDH1A1CYP3A4GFERTSHRTDP1 | |
| SCHEMBL29341640 | 0.82 | ABAT (0.46) | MAOBLOXL2MAPTCA2CA9 | |
| SCHEMBL11320245 | 0.81 | IDO1 (0.41) | TSHRGAARAB9ACA2CA9 | |
| SCHEMBL11316154 | 0.81 | ESR1 (0.42) | ALDH1A1CYP3A4TSHRTDP1MAOB | |
| SCHEMBL437438 | 0.79 | IDO1 (0.50) | APPCA2MEN1KMT2A | |
| SCHEMBL5544633 | 0.78 | GFER (0.52) | ALDH1A1CYP3A4GFERTSHRTDP1 | |
| Dalfampridine SCHEMBL28330621 | 0.78 | MAPT (0.43) | ALDH1A1CYP3A4TSHRTDP1MAOB | |
| SCHEMBL12548720 | 0.77 | MGLL (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3961 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119708088-A | Disaccharide-acylhydrazone or disaccharide-hydrazide linker, sugar engineering antibody based on same, sugar chain fixed-point antibody-drug conjugate and application | 上海糖岭生物医药有限责任公司 | 2025-03-28 | — | — | CN | claimed |
| US-12043670-B2 | Anti-BCMA antibody-drug conjugates and methods of use | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2024-07-23 | — | — | US | claimed |
| US-20240239885-A1 | ANTIBODY CONJUGATE COMPRISING ANTI-P-CADHERIN ANTIBODY AND USES THEREOF | WuXi Biologics Ireland Limited (IE) | 2024-07-18 | — | — | US | claimed |
| CN-118339165-A | Antibody-drug conjugates and methods of use thereof | R.P.谢勒技术有限责任公司 | 2024-07-12 | — | — | CN | claimed |
| EP-4392077-A2 | TUMOR-ASSOCIATED CALCIUM SIGNAL TRANSDUCER 2 (TACSTD2) ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE THEREOF | R.P. Scherer Technologies, LLC (US) | 2024-07-03 | — | — | EP | claimed |
| EP-4393515-A1 | ANTI-CLDN-18.2 ANTIBODY-DRUG CONJUGATE AND USE THEREOF | Shanghai Junshi Biosciences Co., Ltd. (CN) | 2024-07-03 | — | — | EP | claimed |
| EP-4392456-A2 | ANTIBODIES HAVING HUMANIZED FRAMEWORK REGIONS | R.P. Scherer Technologies, LLC (US) | 2024-07-03 | — | — | EP | claimed |
| US-12023316-B2 | FAP-activated therapeutic agents, and uses related thereto | BACH BIOSCIENCES, LLC (US) | 2024-07-02 | — | — | US | claimed |
| CN-113967258-B | FAP-activated therapeutic agents and related uses | 塔夫茨大学信托人 | 2024-07-02 | — | — | CN | claimed |
| WO-2024133815-A1 | ANTIBODY-DRUG CONJUGATES WITH MASKED PBD DIMERS | SYNAFFIX B.V. (NL) | 2024-06-27 | — | — | WO | claimed |
| US-20070003589-A1 | Coatings for implantable medical devices containing attractants for endothelial cells | ADVANCED CARDIOVASCULAR SYSTEMS, INC. | 2007-01-04 | — | — | US | claimed |
| WO-2006112932-A2 | COATINGS FOR IMPLANTABLE MEDICAL DEVICES CONTAINING ATTRACTANTS FOR ENDOTHELIAL CELLS | ADVANCED CARDIOVASCULAR SYSTEMS, INC. (US) | 2006-10-26 | — | — | WO | claimed |
| US-20060116422-A1 | Prodrugs built as multiple self-elimination-release spacers | SYNTARGA B.V. (NL) | 2006-06-01 | — | — | US | claimed |
| US-20050233948-A1 | Drug complex for treatment of metastatic prostate cancer | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 2005-10-20 | — | — | US | claimed |
| EP-0799827-B1 | ACRYLAMIDE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | KYORIN SEIYAKU KK (JP) | 2004-05-12 | — | — | EP | claimed |
| US-20030195152-A1 | Polymeric conjugates of antitumor agents | PHARMACIA ITALIA, S.P.A. (IT) | 2003-10-16 | — | — | US | claimed |
| EP-1317287-A2 | POLYMERIC CONJUGATES OF ANTITUMOR AGENTS | Pharmacia Italia S.p.A. (IT) | 2003-06-11 | — | — | EP | claimed |
| US-20030035804-A1 | Drug complex for treatment of metastatic prostate cancer | BETH ISRAEL DEACONESS MEDICAL CENTER (US) | 2003-02-20 | — | — | US | claimed |
| WO-2002007770-A2 | POLYMERIC CONJUGATES OF ANTITUMOR AGENTS | PHARMACIA ITALIA S.P.A. (IT) | 2002-01-31 | — | — | WO | claimed |
| US-4169939-A | PROCESSES FOR THE PRODUCTION OF 3',4'-DIDEOXYKANAMYCIN B | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1979-10-02 | — | — | US | claimed |